Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized protein R455 (MIMI_R455)

What is the genomic context of MIMI_R455 and how does it compare to characterized mimivirus proteins?

MIMI_R455 is an uncharacterized protein encoded in the Acanthamoeba polyphaga mimivirus genome. While specific information about R455 is limited, we can contextualize it within the framework of known mimivirus proteins. Mimivirus has a large genome (approximately 1.2 million base pairs) encoding over 900 proteins, many of which remain uncharacterized.

Based on studies of other mimivirus proteins, we know that proteins designated with "R" typically indicate they are encoded on the positive strand of the genome. For comparison, characterized mimivirus proteins include L442, L724, L829, R387, and R135, which have been identified as DNA-associated proteins crucial for viral replication . These proteins remain associated with viral DNA even after extraction, suggesting they play important roles in protecting and organizing the viral genome.

• Upstream and downstream genes

• Conserved promoter elements

• Potential operonic structures

• Phylogenetic distribution across related giant viruses

What structural and sequence features characterize MIMI_R455?

While specific structural information about R455 is not directly available in the search results, researchers interested in this protein should conduct bioinformatic analyses to predict its structural features. Based on approaches used for other mimivirus proteins, the following analyses are recommended:

• Primary sequence analysis using multiple sequence alignment with related viruses

• Secondary structure prediction using tools like PSIPRED, JPred, or SOPMA

• Domain architecture identification using InterProScan and SMART

• Tertiary structure prediction using AlphaFold2 or I-TASSER

• Post-translational modification site prediction

For comparison, other mimivirus proteins such as R135 have been identified as putative GMC-type oxidoreductases , suggesting enzymatic functions. Researchers should look for conserved motifs, catalytic residues, or structural similarities to proteins of known function when analyzing R455.

Below is a table summarizing typical bioinformatic analyses for uncharacterized viral proteins:

How can MIMI_R455 be distinguished from other mimivirus proteins in experimental settings?

Distinguishing MIMI_R455 from other mimivirus proteins requires specific experimental approaches. Based on methods used for other mimivirus proteins, researchers should consider:

• Generation of specific antibodies against recombinant R455 for immunoprecipitation and Western blot analysis

• Expression of tagged versions (His, FLAG, GFP) of R455 for affinity purification

• Mass spectrometry-based identification following protein separation

• Creation of knockout or knockdown systems to observe phenotypic changes

For example, in studies of other mimivirus proteins, researchers used matrix-assisted laser desorption/ionization time-of-flight and liquid chromatography–mass spectrometry to identify specific proteins that remained associated with viral DNA . Similar approaches could be applied to identify and characterize R455.

What expression systems are optimal for producing recombinant MIMI_R455 for functional studies?

Selecting an appropriate expression system for MIMI_R455 requires careful consideration of protein characteristics and experimental goals. Based on approaches used for other viral proteins, the following systems should be evaluated:

• Bacterial expression (E. coli): Typically the first choice due to simplicity and high yield

  • BL21(DE3) for basic expression

  • Rosetta or Origami strains for proteins with rare codons or disulfide bonds

  • Fusion with solubility tags (MBP, SUMO, GST) to enhance solubility

• Yeast expression (P. pastoris, S. cerevisiae): For proteins requiring eukaryotic post-translational modifications

  • Methanol-inducible systems for controlled expression

  • Secretory expression for easier purification

• Insect cell expression (Sf9, Sf21, High Five): For complex viral proteins

  • Baculovirus expression vector system (BEVS)

  • Flash-BAC system for rapid recombinant virus generation

• Mammalian expression (HEK293, CHO): For proteins requiring complex folding or modifications

  • Transient or stable expression options

  • Inducible promoter systems for toxic proteins

The following table compares key parameters for these expression systems:

For viral DNA-binding proteins similar to those identified in mimivirus (L442, L724, L829, R387, and R135) , E. coli expression systems have been successfully used, but optimization of solubility often requires testing multiple fusion partners.

How can single-cell transfection methods be applied to study MIMI_R455 function in Acanthamoeba cells?

Single-cell transfection methodologies, particularly microinjection, provide powerful tools for studying mimivirus proteins like R455 in their natural host environment. Based on successful approaches with mimivirus DNA:

• Microinjection protocol for Acanthamoeba cells:

  • Culture Acanthamoeba castellanii in PYG medium at 28°C

  • Transfer cells to starvation medium (Page's amoeba saline) 24 hours before injection

  • Prepare injection solution containing purified R455 protein or expression vector

  • Include fluorescent marker (e.g., rhodamine dextran) to verify successful injection

  • Monitor injected cells for phenotypic changes using phase contrast and fluorescence microscopy

• Alternative transfection methods:

  • Electroporation (optimal parameters: 850 V, 25 μF, 200 Ω)

  • Lipofection with specialized reagents for amoeba

  • DEAE-dextran mediated transfection

When designing experiments using these approaches, researchers should consider:

• Including appropriate controls (cells injected with buffer or non-relevant protein)

• Using fluorescent protein fusions to track localization

• Performing time-course analysis to capture dynamic processes

• Implementing rescue experiments with wild-type protein following knockdown

The successful generation of infectious mimivirus virions through direct transfection of viral DNA into Acanthamoeba castellanii demonstrates the feasibility of these approaches for studying individual viral proteins .

What purification strategies yield the highest purity and activity of recombinant MIMI_R455?

Purification of recombinant MIMI_R455 should be tailored to its predicted characteristics, experimental requirements, and expression system. Based on approaches used for other DNA-binding viral proteins:

• Initial extraction and clarification:

  • Cell lysis optimization (sonication, French press, or chemical lysis)

  • Clarification by centrifugation (typically 20,000 × g, 30 min)

  • Filtration through 0.45 μm filters

• Affinity chromatography options:

  • His-tag purification using Ni-NTA or TALON resin

  • GST-fusion purification using glutathione sepharose

  • MBP-fusion purification using amylose resin

  • DNA-affinity chromatography for potential DNA-binding proteins

• Secondary purification steps:

  • Ion exchange chromatography (cation or anion exchange depending on pI)

  • Size exclusion chromatography for final polishing and buffer exchange

  • Heparin affinity for DNA-binding proteins

• Considerations for DNA-binding proteins:

  • High salt washes (0.5-1.0 M NaCl) to remove bound nucleic acids

  • DNase/RNase treatment during lysis

  • Polyethyleneimine precipitation to remove nucleic acids

The following purification workflow has been effective for DNA-binding proteins similar to those identified in mimivirus:

$\text{Cell Lysis} \rightarrow \text{Clarification} \rightarrow \text{Affinity Chromatography} \rightarrow \text{Tag Removal} \rightarrow \text{Ion Exchange} \rightarrow \text{Size Exclusion}$

For proteins similar to the DNA-associated proteins identified in mimivirus (L442, L724, L829, R387, and R135), researchers should be aware that tight DNA binding may require specialized extraction conditions .

How can protein-DNA interactions between MIMI_R455 and viral genomic DNA be characterized?

Characterizing protein-DNA interactions for MIMI_R455 requires multiple complementary approaches. Based on successful methodologies used with other DNA-binding viral proteins:

• In vitro binding assays:

  • Electrophoretic Mobility Shift Assay (EMSA) with labeled DNA fragments

  • Fluorescence Anisotropy for quantitative binding kinetics

  • Surface Plasmon Resonance (SPR) for real-time interaction kinetics

  • Microscale Thermophoresis for binding under native conditions

• Sequence specificity determination:

  • Systematic Evolution of Ligands by Exponential Enrichment (SELEX)

  • Chromatin Immunoprecipitation followed by sequencing (ChIP-seq)

  • DNA footprinting to identify protected regions

• Structural characterization of complexes:

  • X-ray crystallography of protein-DNA complexes

  • Cryo-electron microscopy for larger assemblies

  • Nuclear Magnetic Resonance (NMR) for dynamic interaction analysis

For proteins like L442, which has been identified as playing a major role in protein-DNA interactions in mimivirus, researchers have proposed using X-ray crystallography to determine the exact structure and function . Similar approaches would be valuable for R455 if it shows DNA-binding properties.

When designing these experiments, researchers should:

• Use both random and genomic DNA sequences to assess specificity

• Test different buffer conditions (varying salt, pH, and divalent cations)

• Examine the effects of post-translational modifications on binding affinity

• Consider potential cooperative binding with other viral or host proteins

What approaches can identify potential interaction partners of MIMI_R455 in both viral and host contexts?

Identifying interaction partners of MIMI_R455 requires multi-faceted approaches spanning both computational predictions and experimental validations:

• Computational prediction methods:

  • Protein-protein interaction (PPI) prediction algorithms

  • Structural docking simulations

  • Co-evolution analysis across viral species

  • Genomic context and gene neighborhood analysis

• Affinity-based experimental approaches:

  • Co-immunoprecipitation with antibodies against R455

  • Pull-down assays using tagged recombinant R455

  • Proximity labeling methods (BioID, APEX)

  • Yeast two-hybrid screening against viral and host protein libraries

• Advanced proteomics approaches:

  • Cross-linking mass spectrometry (XL-MS)

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS)

  • Thermal proteome profiling

  • Native mass spectrometry for intact complexes

• In situ visualization:

  • Fluorescence resonance energy transfer (FRET)

  • Bimolecular fluorescence complementation (BiFC)

  • Proximity ligation assay (PLA)

  • Live-cell imaging with fluorescently tagged proteins

The following decision tree can guide the selection of appropriate methods:

$\text{Initial Prediction} \rightarrow \text{Preliminary Validation (Y2H/CoIP)} \rightarrow \text{Confirmation (Reciprocal Pulldown)} \rightarrow \text{Functional Validation} \rightarrow \text{Structural Characterization}$

Studies of other mimivirus proteins have revealed interactions between viral DNA and proteins such as L442, L724, L829, R387, and R135 . Similar approaches could reveal whether R455 interacts with these proteins or forms part of the same functional complexes.

How might post-translational modifications affect MIMI_R455 function and localization?

Post-translational modifications (PTMs) often play crucial roles in regulating viral protein function, localization, and interactions. For MIMI_R455, researchers should consider:

• Prediction and identification of potential PTMs:

  • Phosphorylation sites using tools like NetPhos, PhosphoSitePlus

  • Glycosylation sites using NetNGlyc, NetOGlyc

  • Ubiquitination and SUMOylation sites

  • Methylation and acetylation prediction

• Experimental detection methods:

  • Mass spectrometry-based PTM mapping

    • Enrichment strategies for specific modifications

    • Multiple protease digestions for comprehensive coverage

  • Western blotting with PTM-specific antibodies

  • Radioactive labeling with specific precursors

  • Chemical labeling approaches

• Functional impact assessment:

  • Site-directed mutagenesis of modified residues

  • Expression of phosphomimetic/phosphodeficient mutants

  • Inhibitor studies targeting specific modifying enzymes

  • Temporal analysis during infection cycle

The following table summarizes key PTMs and their potential impacts on viral proteins:

For mimivirus proteins like L442 that interact with DNA, phosphorylation often regulates binding affinity and specificity, which could be similarly important for R455 if it shares functional characteristics .

How does the presence or absence of MIMI_R455 impact mimivirus replication cycle?

Understanding the role of MIMI_R455 in the mimivirus replication cycle requires systematic approaches to observe phenotypic changes when the protein is manipulated. Based on methodologies used to study other mimivirus proteins:

• Gene knockout/knockdown approaches:

  • CRISPR-Cas9 modification of viral genome

  • Antisense oligonucleotides targeting R455 mRNA

  • RNA interference if applicable in the system

  • Dominant-negative mutant expression

• Complementation and rescue experiments:

  • Trans-complementation with wild-type protein

  • Structure-function analysis with domain deletion constructs

  • Chimeric protein expression to identify functional domains

• Temporal analysis during infection:

  • Time-course sampling post-infection

  • Quantitative PCR for viral replication

  • Immunofluorescence microscopy for localization changes

  • Electron microscopy for ultrastructural assessment

• Viral factory formation analysis:

  • Fluorescence microscopy of viral factories

  • Co-localization with known factory markers

  • Live-cell imaging to track factory dynamics

Studies of other mimivirus proteins have demonstrated that DNA-associated proteins like L442 play crucial roles in viral replication. For example, when viral DNA was treated with proteinase K to remove these proteins, it was no longer able to generate infectious virions upon transfection . This suggests that if R455 has similar DNA-binding properties, it might be essential for viral replication.

What computational models can predict MIMI_R455 function based on sequence and structural information?

Computational approaches offer valuable insights into potential functions of uncharacterized proteins like MIMI_R455:

• Homology-based function prediction:

  • PSI-BLAST for distant homology detection

  • HHpred for profile-profile alignment

  • FFAS for fold recognition

  • FunFam classification for functional family assignment

• Structure-based function prediction:

  • Active site template matching

  • Binding pocket analysis

  • Electrostatic surface potential mapping

  • Molecular dynamics simulations for conformational sampling

• Network-based approaches:

  • Protein-protein interaction network analysis

  • Gene neighborhood conservation

  • Phylogenetic profiling

  • Co-expression analysis where data is available

• Machine learning methods:

  • Random forest classifiers

  • Support vector machines

  • Deep learning approaches (CNNs, GNNs)

  • Integration of multiple data types

The following workflow represents a comprehensive computational function prediction strategy:

$\text{Sequence Analysis} \rightarrow \text{Structure Prediction} \rightarrow \text{Template Matching} \rightarrow \text{Molecular Dynamics} \rightarrow \text{Network Integration} \rightarrow \text{Experimental Validation}$

For other mimivirus proteins like L442, computational analyses have suggested DNA-binding functions, which were later confirmed experimentally . Similar approaches might provide insights into R455 function prior to extensive laboratory work.

How can contradictions in experimental data about MIMI_R455 be reconciled through methodological improvements?

When faced with contradictory experimental results regarding MIMI_R455 function or characteristics, researchers should consider:

• Sources of experimental variability:

  • Expression system differences (bacterial vs. eukaryotic)

  • Tag interference with protein function

  • Buffer conditions affecting activity or folding

  • Protein concentration effects on oligomerization

  • Sample preparation artifacts

• Methodological reconciliation approaches:

  • Orthogonal method validation

  • Standardization of experimental conditions

  • Blind testing protocols

  • Inter-laboratory validation studies

  • Meta-analysis of multiple datasets

• Advanced technologies to resolve contradictions:

  • Single-molecule techniques to detect heterogeneity

  • Native mass spectrometry for conformational states

  • Hydrogen-deuterium exchange for dynamic analyses

  • Cryo-EM for structural heterogeneity assessment

• Integrated data analysis frameworks:

  • Bayesian integration of multiple data sources

  • Weighted evidence approaches

  • Statistical modeling of conflicting results

  • Machine learning for pattern recognition across datasets

The table below outlines common contradictions in viral protein characterization and resolution strategies:

For mimivirus proteins, contradictory results have been observed regarding their roles in viral replication. Researchers resolved these by using multiple complementary approaches, including microinjection of viral DNA with and without associated proteins .

What are the primary challenges in crystallizing MIMI_R455 for structural determination and how can they be overcome?

Crystallizing viral proteins like MIMI_R455 presents several challenges that require systematic approaches to overcome:

For DNA-binding proteins like those identified in mimivirus (L442, L724, L829, R387, and R135), the presence of bound nucleic acids often hinders crystallization . Strategies such as high-salt treatment, nuclease digestion, or crystallization of protein-DNA complexes might be necessary.

Decision tree for structural determination of challenging viral proteins:

$\text{Construct Optimization} \rightarrow \text{Initial Screening} \rightarrow \text{Optimization} \overset{\text{Success}}{\underset{\text{Failure}}{\rightarrow}} \text{Alternative Methods}$

How can the specificity of antibodies against MIMI_R455 be validated for research applications?

Developing and validating specific antibodies against MIMI_R455 requires rigorous testing to ensure specificity and applicability across experimental techniques:

• Initial antibody production considerations:

  • Antigen design (full-length vs. peptide)

  • Host species selection

  • Polyclonal vs. monoclonal development

  • Validation controls planning

• Comprehensive validation framework:

  • Western blot against recombinant protein and viral lysates

  • Immunoprecipitation efficiency testing

  • Immunofluorescence in infected vs. uninfected cells

  • ELISA for quantitative binding assessment

  • Knockout/knockdown controls

• Cross-reactivity testing:

  • Against related viral proteins

  • Against host cell proteins

  • Peptide competition assays

  • Pre-adsorption tests

• Application-specific validation:

  • ChIP-grade testing for chromatin studies

  • Fixed vs. live-cell compatibility

  • Buffer condition optimization

  • Species cross-reactivity if relevant

The following validation checklist ensures antibody specificity:

For mimivirus proteins, antibody specificity is particularly important due to the large number of viral proteins and potential cross-reactivity .

What artificial intelligence and machine learning approaches can accelerate MIMI_R455 research?

Artificial intelligence and machine learning offer powerful tools to accelerate research on uncharacterized proteins like MIMI_R455:

• Sequence-based prediction:

  • Deep learning for function prediction

  • Recurrent neural networks for sequence patterns

  • Transfer learning from related viral proteins

  • Attention mechanisms for key residue identification

• Structure prediction and analysis:

  • AlphaFold2 for 3D structure prediction

  • Graph neural networks for binding site prediction

  • Molecular dynamics trajectory analysis

  • Generative models for protein design

• Experimental design optimization:

  • Active learning for crystallization condition selection

  • Bayesian optimization for expression condition screening

  • Reinforcement learning for directed evolution

  • Automated image analysis for phenotypic screens

• Literature mining and knowledge integration:

  • Natural language processing for viral protein literature

  • Knowledge graph construction and mining

  • Automated hypothesis generation

  • Cross-domain knowledge transfer

The implementation of AI approaches follows this general workflow:

$\text{Data Collection} \rightarrow \text{Feature Engineering} \rightarrow \text{Model Training} \rightarrow \text{Validation} \rightarrow \text{Prediction} \rightarrow \text{Experimental Testing}$

For mimivirus proteins, AI approaches could help predict which uncharacterized proteins might be involved in DNA binding or other functions based on patterns learned from characterized proteins like L442, L724, L829, R387, and R135 .